Ascendis Pharma A/S Regulatory Update Transcript
Good day, ladies and gentlemen. Thank you for standing by. Welcome to Ascendis Pharma Regulatory Update Conference Call. (Operator Instructions) Please note that today's conference may be recorded.
I will now hand the conference over to your speaker host, Tim Lee, Senior Director of Investor Relations. Please go ahead.
/-
Thank you, operator, and thank you, everyone, for joining our regulatory update call this morning. I'm Tim Lee, Senior Director, Investor Relations. Joining me on the call today is Jan Mikkelsen, President and Chief Executive Officer.
Before we begin, I'd like to remind you that this call will contain forward-looking statements that are intended to be covered under the safe harbor provided by the Private Securities Litigation Reform Act. Examples of such statements may include, but are not limited to statements regarding our plans to address and resolve concerns raised by the FDA and bring TransCon PTH to the market in the U.S. and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
